Future Fertility Inc. is a Canada-based artificial intelligence (AI) med-tech startup focusing on reproductive innovations with image analysis software tools (VIOLET™ & MAGENTA™) that evaluate the reproductive potential of human eggs (oocytes). This non-invasive and instantaneous image analysis tool only requires a single image of an egg taken from a standard light microscope. To date, Violet is able to predict whether or not an egg will successfully fertilize with 90% accuracy, and the chance of it reaching a blastocyst with almost 65% accuracy. These findings have been reproduced and validated in multiple In-Vitro Fertilization clinics and our innovations have been presented at international conferences.

This significant innovation provides objective insights into the quality of an egg, leading to personalized patient feedback, tailored treatment plans, and improved IVF outcomes for patients in future treatments.

Our vision is to unlock the future of personalized fertility care worldwide. Our mission is to bring the power of AI to collaborate with fertility professionals, optimize reproductive care, and empower patients at all stages of their fertility journey.

Founded in 2018, Future Fertility is recognized for pioneering the first AI-based tool to score egg quality, bridging a critical gap in fertility treatment by providing objective, science-backed solutions for patients, doctors, and embryologists globally.